2002
DOI: 10.1016/s0041-1345(02)03579-0
|View full text |Cite
|
Sign up to set email alerts
|

Five-year experience with the new Eurotransplant kidney allocation system, 1996 to 2001

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
2

Year Published

2004
2004
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 4 publications
0
4
0
2
Order By: Relevance
“…avoids long waiting times for those with uncommon HLA profiles by incorporating an index of ''matchability.'' This approach is used successfully by Eurotransplant (17,(24)(25)(26)(27). The Eurotransplant algorithm balances a preference for well-matched kidneys against the likelihood of obtaining a good match, thereby maintaining HLA matching as part of the algorithm without unfairly disadvantaging patients for whom it is difficult to find a good match.…”
Section: Discussionmentioning
confidence: 99%
“…avoids long waiting times for those with uncommon HLA profiles by incorporating an index of ''matchability.'' This approach is used successfully by Eurotransplant (17,(24)(25)(26)(27). The Eurotransplant algorithm balances a preference for well-matched kidneys against the likelihood of obtaining a good match, thereby maintaining HLA matching as part of the algorithm without unfairly disadvantaging patients for whom it is difficult to find a good match.…”
Section: Discussionmentioning
confidence: 99%
“…52 Points waiting, highly-sensitised, rare HLA-phenotype and paediatric patients, and equalising the international imbalances in organ exchange. 54,55 Eurotransplant was the first organisation to develop special allocation programs for specific groups of patients ( Figure 2). The Acceptable Mismatch Program (AMP) was introduced in 1996 for highly-sensitised patients (PRA >85%), where it is determined which HLA-antigens the patient does not have antibodies against, and priority is given for any donor with acceptable antigens.…”
Section: New Zealandmentioning
confidence: 99%
“…Die chi rur gi schen Teams der Ent nahme wer den durch Mit ar bei ter der deutschen Trans plan ta ti ons zen tren ge bil det, die über eine ent spre chen de Ex per ti se verfü gen. Die Vor raus set zun gen (Hirn tod diagno s tik, Kri te ri en für Or gan spen der) sowie der or ga ni sa to ri sche Ab lauf ei ner Entnah me und die Or ga nal lo ka ti on sind klar ge re gelt [7,11,12].…”
Section: Pan Kre As or Gan Ent Nah Meunclassified